(VIANEWS) - Coastal Financial Corporation (CCB), Tenaris S.A. (TS), Harmony Biosciences Holdings (HRMY) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Coastal Financial Corporation (CCB)
65.2% sales growth and 16.34% return on equity
Coastal Financial Corporation is the bank holding firm for Coastal Community Bank. It provides a variety of banking products and services to professionals and small- to medium-sized business owners, as well as individuals, in Washington's Puget Sound area. You can deposit in a variety of products including demand and savings, checking, money market, and time deposits. It offers industrial and commercial loans. These include term loans and small-business administration loans. Commercial lines of credit are available. Borrowing base loans and residential loans can also be offered. Remote deposit capture, mobile banking and online banking are all available. Debit cards can also be obtained. The company also offers cash management and business accounts. These include business checking, savings, and Treasury services. The company has 15 fully-service banks. Coastal Financial Corporation was established in 1997. It is headquartered at Everett in Washington.
Earnings Per Share
As for profitability, Coastal Financial Corporation has a trailing twelve months EPS of $1.51.
PE Ratio
Coastal Financial Corporation has a trailing twelve months price to earnings ratio of 33.88. Meaning, the purchaser of the share is investing $33.88 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.34%.Sales Growth
Coastal Financial Corporation's sales growth is 106.3% for the current quarter and 65.2% for the next.
Yearly Top and Bottom Value
Coastal Financial Corporation's stock is valued at $51.22 at 05:22 EST, under its 52-week high of $54.41 and way above its 52-week low of $35.61.
2. Tenaris S.A. (TS)
56.3% sales growth and 14.72% return on equity
Tenaris S.A., through its subsidiaries, produces and sells seamless and welded steel tubular products; and provides related services for the oil and gas industry, and other industrial applications. The company offers steel casings, tubing products, mechanical and structural pipes, cold-drawn pipes, and premium joints and couplings; coiled tubing products for oil and gas drilling and workovers, and subsea pipelines; and umbilical tubing products; and tubular accessories. It also provides sucker rods, industrial equipment, heat exchangers, and utility conduits for buildings, as well as sells energy and raw materials. Additionally, it offers financial services. The company operates in North America, South America, Europe, the Middle East and Africa, and the Asia Pacific. Tenaris S.A. was incorporated in 2001 and is based in Luxembourg, Luxembourg. Tenaris S.A. is a subsidiary of Techint Holdings S.Ã r.l.
Earnings Per Share
As for profitability, Tenaris S.A. has a trailing twelve months EPS of $0.22.
PE Ratio
Tenaris S.A. has a trailing twelve months price to earnings ratio of 140.89. Meaning, the purchaser of the share is investing $140.89 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.72%.Growth Estimates Quarters
For the current quarter, the company expects to grow by 76.8% and 79% respectively.Volume
Tenaris S.A.'s current reported volume is 1663490, which is 23.99% lower than its average volume (2188580).
3. Harmony Biosciences Holdings (HRMY)
36.2% sales growth and 62.78% return on equity
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy in the United States. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
Earnings per Share
Harmony Biosciences Holdings' trailing 12 month EPS is $2.58.
PE Ratio
Harmony Biosciences Holdings' trailing 12-month price-earnings ratio is 23.44. The purchaser of the shares is therefore investing $23.44 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 62.78%.Earnings before Interest, Taxes and Depreciation
Harmony Biosciences Holdings has an EBITDA of 8.66.
Annual Top and Bottom Value
Harmony Biosciences Holdings' stock was valued at $60.48 in 05:22 EST. This is below its 52 week high of $61.55 but well above its low 52-week of $31.54.
Growth Estimates Quarters
For the current quarter, the company expects to grow by 52.6% and 40 percent respectively.4. Provident Bancorp (PVBC)
23% sales growth and 8.41% return on equity
Provident Bancorp, Inc. is the bank holding firm for The Provident Bank. It provides financial services to small and large businesses throughout the United States. You can get checking, deposit certificates, term certificate and negotiable orders of withdrawal. It also offers commercial real estate and multi-family residential property, commercial construction and land development as well as mortgage warehouse and one-to four-family residential loans. The company invests in securities and bonds of the state as well as municipal bonds. It operated its principal office, six branches offices in Amesbury, Newburyport and Bedford, Massachusetts. The Bedford, Exeter and Portsmouth offices are located in New Hampshire. There were also two loan production offices in Ponte Vedra and Massachusetts. It was established in Amesbury in Massachusetts in 1828.
Earnings per Share
Provident Bancorp's trailing twelve-month EPS is $1.16.
PE Ratio
The trailing 12 months earnings to price ratio for Provident Bancorp is 5.45. The purchaser of the shares is therefore investing $5.45 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 8.41%.Growth Estimates Quarters
For the current quarter, the company expects to grow by 6.7% for the quarter and 42.9% the following.5. PCB Bancorp (PCB)
19.3% sales growth and 12.74% return on equity
PCB Bancorp is the bank holding firm for Pacific City Bank. It provides a variety of banking products and services to both individuals and businesses within the small and medium market in Southern California. It offers time, demand, money market and savings deposits as well as certificates and deposit. Remote deposit capture is available, along with courier deposit services and positive pay services. Zero balance accounts are also offered. The company also offers real estate loans and commercial and industrial loans. It also offers unsecured and secured lines of credit for automobiles, term loans and loans to individuals. This includes business loans such as manufacturing, wholesale, retail, hospitality and other types. The company also offers automated teller machines and debit cards as well as cashier's and wire transfers, treasury management and wire transfer and automated clearinghouse services. It also provides cash management and services online, by telephone and mail. The company operates via a network that includes 11 fully-service branches located in Los Angeles, Orange, and Bayside counties in California, as well as a branch in Englewood Cliffs and Bayside in New Jersey. There are 9 loan production centers that the company operates in Irvine, Artesia and Los Angeles, California, Annandale and Virginia, Chicago, Illinois, Bellevue and Washington, Aurora and Colorado, Carrollton and Texas, as well as New York, New York. Named previously Pacific City Financial Corporation, the company changed its name in July 2019 to PCB Bancorp. PCB Bancorp is located in Los Angeles and was established in 2003.
Earnings per Share
For profitability, PCB Bancorp's trailing twelve-month EPS is $1.36
PE Ratio
PCB Bancorp's trailing 12-month price-to-earnings ratio is 13.73. The purchaser of the shares is therefore investing $13.73 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 12.74%.